Follow the Camp4 Therapeutics Corp stock price and the full directors' dealings record of the company, a publicly traded company based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €260.4m. The latest transaction was reported on 31 August 2026 (Cession). Among the most active insiders: Schwab Andrew J.. All data is free.
31
Insider Decl.
n/a
Thresholds
€16m
12 ops.
Buy Volume
€2m
6 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Camp4 Therapeutics Corp Strong Buy (bullish), based on 6 analysts. Average price target: US$9.92.
57Σ signal
Buys €16m€2m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Camp4 Therapeutics Corp es una empresa enfocada en el desarrollo de terapias innovadoras para enfermedades genéticas. Emplea enfoques de edición genómica para crear soluciones terapéuticas.